【肺纖維化】《Rein: RNTX》與《Qureight》合作利用DL進行「特發性肺纖維化」二期臨床

 【肺纖維化】《Rein: RNTX》與《Qureight》合作利用深度學習進行「特發性肺纖維化(IPF)」二期臨床

 文章出處  

PRNEWSWire 

 

 原文標題  

Rein Therapeutics and Qureight Ltd Announce Planned Integration of Deep-Learning Platform for Phase 2 Trial of LTI-03 in Patients with IPF 

 

 Twitter  

https://x.com/aimedadviser/status/1918105928966259134 

 

 文章序號  

7874 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2025 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.